|
1
|
Urbaniak A, Thummel KE, Alade AN, Rettie AE, Prasad B, De Nicolò A, Martin JH, Sheppard DN, Jarvis MF. Experimental pharmacology in precision medicine. Pharmacol Res Perspect 2023; 11:e01147. [PMID: 37885364 PMCID: PMC10603287 DOI: 10.1002/prp2.1147] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Accepted: 10/04/2023] [Indexed: 10/28/2023] Open
Affiliation(s)
- Alicja Urbaniak
- Department of Biochemistry and Molecular BiologyUniversity of Arkansas for Medical SciencesLittle RockArkansasUSA
| | | | - Ayoade N. Alade
- School of PharmacyUniversity of WashingtonSeattleWashingtonUSA
| | - Allan E. Rettie
- School of PharmacyUniversity of WashingtonSeattleWashingtonUSA
| | - Bhagwat Prasad
- Department of Pharmaceutical SciencesWashington State UniversitySpokaneWashingtonUSA
| | | | - Jennifer H. Martin
- The University of Newcastle Hunter Medical Research InstituteNew LambtonNew South WalesAustralia
| | - David N. Sheppard
- School of Physiology, Pharmacology and NeuroscienceUniversity of BristolBristolUK
| | - Michael F. Jarvis
- Pharmaceutical SciencesUniversity of Illinois‐ChicagoChicagoIllinoisUSA
| |
Collapse
|
|
2
|
Martin JH, Olver I. Precision medicine-based drug treatment individualization in oncology. Br J Clin Pharmacol 2020; 87:223-226. [PMID: 33314335 DOI: 10.1111/bcp.14512] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2020] [Revised: 07/20/2020] [Accepted: 08/05/2020] [Indexed: 12/11/2022] Open
Affiliation(s)
- Jennifer H Martin
- Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, New South Wales, Australia.,PREDICT Program, on behalf of Cancer Council NSW, Woolloomooloo, New South Wales, Australia
| | - Ian Olver
- School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.,PREDICT Program, on behalf of Cancer Council NSW, Woolloomooloo, New South Wales, Australia
| |
Collapse
|
|
3
|
Martin JH, Bowden NA. DRUG REPURPOSING-Overcoming the translational hurdles to clinical use. Pharmacol Res Perspect 2019; 7:e00548. [PMID: 31788319 PMCID: PMC6880183 DOI: 10.1002/prp2.548] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Revised: 10/23/2019] [Accepted: 10/28/2019] [Indexed: 12/26/2022] Open
Affiliation(s)
- Jennifer H. Martin
- Centre for Human Drug ResearchSchool of Medicine and Public HealthUniversity of NewcastleHunter Medical Research InstituteNew Lambton HeightsAustralia
| | - Nikola A. Bowden
- Centre for Human Drug ResearchSchool of Medicine and Public HealthUniversity of NewcastleHunter Medical Research InstituteNew Lambton HeightsAustralia
| |
Collapse
|
|
4
|
Sminia P, Westerman BA. Blood-brain barrier crossing and breakthroughs in glioblastoma therapy. Br J Clin Pharmacol 2016; 81:1018-20. [PMID: 26744058 DOI: 10.1111/bcp.12881] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2015] [Revised: 12/23/2015] [Accepted: 01/01/2016] [Indexed: 10/22/2022] Open
Affiliation(s)
- P Sminia
- Department of Radiation Oncology, VU University Medical Center, Amsterdam
| | - B A Westerman
- Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands
| |
Collapse
|